Astonea Labs Ltd — Board Meeting, 27-02-2026: Board Meeting
27-02-2026 | 06:55 pm
27-02-2026 | 06:55 pm
Astonea Labs board okayed diverting ₹6.25 Cr from IPO funds for a 20-21% stake in Damaira Pharma. Also approved ₹415 Cr in related party transactions & up to ₹100 Cr for general investments, all pending shareholder nod at EGM.
No comments yet. Be the first to comment!
